Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)—A randomized, placebo‐controlled phase II feasibility/pilot study

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	James F. Casella, Dana K. Furstenau, Robert J. Adams, Donald J. Brambilla, Jeffrey D. Lebensburger, James J. Fehr, Lori C. Jordan, Allison A. King, Rebecca N. Ichord, Robert C. McKinstry, Michael A. Kraut, Dennis W. Shaw, Desiree A. White, Donna A. Whyte‐Stewart, Radhika Avadhani, Emily A. Barron‐Casella, Alicia D. Cannon, Cyd K. Eaton, Kristin A. Riekert, Joanne E. Shay, Cynthia A. Smith‐Seidel, Diane C. Weiss, Noeleen D. Ostapkovich, Krista Vermillion, Kevin E. Treine, Claire E. Kingsbury, John J. Strouse, Richard E. Thompson, Daniel F. Hanley
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	American Journal of Hematology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Accesso online